Mabtas 100mg Injection

About Mabtas 100mg Injection

Mabtas 100mg Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.Mabtas 100mg Injection is given as an injection under the supervision of doctor. You must take it in a dose as advised by the doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.The most common side effects of this medicine include headache, weakness, edema, infection, and hair loss. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with hepatitis B.Before taking it, tell your doctor if you have heart disease, liver, or planning surgery or vaccination or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. 

Powerful Monoclonal Antibody Therapy

Mabtas 100mg Injection offers targeted treatment with Rituximab, helping to improve outcomes in Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis. Its precise action on abnormal cells makes it a key therapy for oncological and autoimmune indications, underlining its importance in modern medicinal practice.


Proper Handling and Administration

Mabtas 100mg must be diluted and administered via intravenous infusion under the supervision of qualified healthcare professionals. Reconstitution and preparation should always follow the manufacturer's guidelines to ensure patient safety and medication effectiveness. The solution should be stored refrigerated and never frozen to maintain stability.


Safety and Prescription Guidelines

Mabtas 100mg is available only by prescription, emphasizing the need for medical oversight due to its powerful immunomodulating effects. Patients with a known hypersensitivity to Rituximab or any of the excipients should not receive this product. Close monitoring is essential during and after administration to manage potential adverse reactions effectively.